Achilles Therapeutics PLC (ACHL)
1.07
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Achilles Therapeutics Net Income (Quarterly): -19.60M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -19.60M |
June 30, 2024 | -16.38M |
March 31, 2024 | -12.27M |
December 31, 2023 | -18.63M |
September 30, 2023 | -16.68M |
June 30, 2023 | -16.85M |
March 31, 2023 | -17.51M |
December 31, 2022 | -24.06M |
September 30, 2022 | -12.48M |
June 30, 2022 | -17.29M |
Date | Value |
---|---|
March 31, 2022 | -17.36M |
December 31, 2021 | -18.23M |
September 30, 2021 | -12.95M |
June 30, 2021 | -16.16M |
March 31, 2021 | -13.76M |
December 31, 2020 | -12.92M |
September 30, 2020 | -8.21M |
June 30, 2020 | -6.855M |
March 31, 2020 | -5.214M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-24.06M
Minimum
Dec 2022
-5.214M
Maximum
Mar 2020
-14.92M
Average
-16.38M
Median
Jun 2024
Net Income (Quarterly) Benchmarks
Autolus Therapeutics PLC | -82.09M |
Biodexa Pharmaceuticals PLC | -- |
Centessa Pharmaceuticals PLC | -42.57M |
Adaptimmune Therapeutics PLC | -17.62M |
Verona Pharma PLC | -42.96M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 20.42M |
EPS Diluted (Quarterly) | -0.48 |
Enterprise Value | -42.09M |
Earnings Yield | -154.2% |